Gene expression profiles of gastric cancer (GC) were analyzed with bioinformatics tools to identify signature genes associated with prognosis. Four gene expression data sets (accession number: GSE2685, GSE30727, GSE38932 and GSE26253) were downloaded from Gene Expression Omnibus. Differentially expressed genes (DEGs) were screened out using significance analysis of microarrays (SAM) algorithm. P-value < 0.05 and |fold change| >1 were set as the threshold. A co-expression network was constructed for the GC-related genes with package WGCNA of R. Modules were disclosed with WGCNA algorithm. Survival-related signature genes were screened out via COX single-variable regression. A total of 3210 GC-related genes were identified from the 3 data sets. Significantly enriched GO biological process terms included cell death, cell proliferation, apoptosis, response to hormone and phosphorylation. Pathways like viral carcinogenesis, metabolism, EBV viral infection, and PI3K-AKT signaling pathway were significantly over-represented in the DEGs. A gene co-expression network including 2414 genes was constructed, from which 7 modules were revealed. A total of 17 genes were identified as signature genes, such as DAB2, ALDH2, CD58, CITED2, BNIP3L, SLC43A2, FAU and COL5A1. Many signature genes associated with prognosis of GC were identified in present study, some of which have been implicated in the pathogenesis of GC. These findings could not only improve the knowledge about GC, but also provide clues for clinical treatments.
Gastric cancer (GC) is the second most common cause of cancer-related death worldwide. Risk factors of GC include diet, tobacco [1] , infection of Helicobacter pylori and familiar GC [2] . The incidence, diagnostic studies, and therapeutic options have undergone big changes in the last decades, but the prognosis for GC patients remains poor, especially in more advanced stages [3] . Recurrence following surgery is a major problem, and is often the ultimate cause of death.
Molecular pathology can be helpful not only to understand the disease pathogenesis, but also to give useful prognostic molecular markers. Overexpression of p53 has been reported in 17-91% of invasive GC [4] . Sumiyoshi et al. suggest that the elevatedp53 is a marker for an unfavorable prognosis in GC [5] . Yokobori et al. further point out that p53 alters FBXW7 expression and the disruption of both p53 and FBXW7 contributes to poor prognosis in GC [6] . Besides, many biological prognostic factors have been proposed, such as p21 [7, 8], vascular endothelial growth factor (VEGF) [9] , cyclin D2 [10] and HER2 [11] .
Many studies have adopted microarray technology to identify critical genes in GC [12] [13] [14] . Lee et al. report that CDH17 is a prognostic marker for early stage GC [14] . Nishigaki et al. find aberrant expression of R-RAS in GC using microarrays and prove that blocking of the R-RAS-signaling pathway has great potential for GC therapy [15] . Obviously, these gene expression data are not fully utilized due to limited tools or restricted purpose. Mining valuable information with currently available bioinformatics tools from the plenty of gene expression data is of great significance.
In present study, we obtained a great number of GC-related genes via differential analysis of 3 gene expression data sets. Using another data set, a gene co-expression network was constructed for the GC-related genes and modules were disclosed. Then signature genes associated with survival time were screened out via Cox regression analysis.
Materials and methods
Gene expression data. Four gene expression data sets were downloaded from Gene Expression Omnibus [16] . GSE2685 [17] included22 primary human advanced gastric cancer tissues and 8 noncancerous gastric tissues. Affymetrix Human Full Length HuGeneFL Array (Affymetrix Inc., Santa Clara, California, USA) was used. GSE30727 analyzed 30 pairs of normal-cancer stomach tissues using the Affymetrix Human Exon 1.0 ST platform (Affymetrix Inc., Santa Clara, California, USA). GSE38932 [18] contained 12 gastric tumors and 12 paired adjacent non-tumoral gastric tissues. The platform was HEEBO Human oligo array. GSE26253 [19] included 432 formalin fixed paraffin embedded gastric tumor tissues and Illumina HumanRef-8 WG-DASL v3.0 was used (Illumina, USA).
Pre-treatment of raw data. Probes were mapped to genes. For genes corresponding to more than one probe, gene expression levels were determined by the average probe values [20] . Log2 conversion and quantile normalization [21] were applied on data. Genes with more than 20% missing values were removed and others were filled with average expression level.
Differential analysis. Significance analysis of microarrays (SAM) algorithm [22] was adopted to screen out differentially expressed genes (DEGs). SAM can reduce the false-positive rate in multiple testing via controlling false discovery rate (FDR). Relative difference (statistic d) is calculated as follow:
(1) d= S + s 0 Statistic d measures the relative differences in gene expression levels and it is the corrected t. X 1 ' represents the average expression level of a gene under certain state, X 2 ' represents the average expression level of a gene under another state, and s represents the variance of a gene. FDR< 0.05 and log2|fold change| >1 were set as the threshold to screen out DEGs.
Functional enrichment analysis. Gene Onotology (GO) enrichment analysis and pathway enrichment analysis were performed for the DEGs with toppGene [23] , a test based upon hypergeometric distribution. FDR < 0.05 was set as the cut-off value.
Gene co-expression network analysis. A gene co-expression network was constructed for the GC-related genes with package WGCNA (weighted gene co-expression network analysis) [24] of R. The connection coefficient a was calculated for a pair of genes as follow:
Where Xi and Xj represent expression vectors of gene i and gene j, cor represents Pearson correlation coefficient of the two vectors. Pearson correlation coefficient is converted into connection coefficients aij via exponential transformation. Exponential transform can strengthen strong correlation but weaken weak correlation, and thus improve the reliability of the network.
WGCNA algorithm takes topological properties into consideration to identify modules from the network. The algorithm considers not only the two directly connected genes, but also others genes linked with the two genes. It calculates weighting coefficient Wij from connection coefficient aij as follow:
Wij considers overlap in the neighboring genes of node i and node j. Modules were identified via hierarchical clustering of the weighting matrix W.
Survival analysis. After we selected several GC-related genes and then clustered them into different modules basing on the different expressions, the patients were classified as having or not having relapse based on module genes using Support Vector Machine (SVM) [25] . A tenfold crossvalidation method was chosen to evaluate the classification result. Survival-related signature genes were screened out via single-variable Cox regression analysis.
Results

Differentially expressed genes.
A set of 5,524, 8,988 and 20,860 genes are detected in the data sets of GSE2685, GSE38923 and GSE30727, respectively. The box plots are shown in Figure 1 , which indicates a uniform expression distribution of the samples after normalization. According to the criteria (FDR< 0.05 and log2|fold change| > 1), the DEGs were screened out in three data sets which contained both tumor and normal tissues. Consequently, a cohort of1282 DEGs were obtained in GSE2685, 28 DEGs in GSE38932 and 2041 DEGs in GSE30727. As shown in Figure 2 , only a few genes were common among the 3 sets of DEGs, suggesting high heterogeneity in GC samples. The 3 sets of DEGs were combined and a total of 3210 genes were acquired, which were regarded as GC-related genes.
Functional enrichment analysis result. Significantly enriched GO biological process (BP) terms for the DEGs included cell death, cell proliferation, apoptosis, response to hormone and phosphorylation ( Supplementary Table 1A ). Pathway enrichment analysis revealed viral carcinogenesis, metabolism, EBV viral infection, and PI3K-AKT signaling pathway ( Supplementary Table 1B ). These functions and pathways have been implicated in the pathogenesis of GC [26] .
Gene co-expression network and signature genes. To further screen out signature genes from the 3210 GC-related genes, another gene expression data set (GSE25263), which comprised only 432 GC patient samples with clinical information, was acquired from GEO. Same pre-treatment was applied on the raw data. Box plot for the 20 samples randomly selected out of the 432 samples also revealed a uniform expression among samples after normalization ( Figure 3 ). The 3210 GC-related genes showed various expression patterns in the 432 samples ( Figure 4) . A co-expression network including 2414 genes was constructed with WGCNA algorithm, from which 7 modules were identified (Supplementary Table 2 ).
Functional enrichment analysis was performed for the genes in each module. No significant term was enriched in module "green" and terms enriched in module "red" was not associated with GC. GC-related terms were identified in other 5 modules ("Yellow", "blue", "grey", "Brown" and "turquoise") and thus they were considered as GC-related modules.
We found that relapse could well classify patients with different survival time by Kaplan-Meier test (P < 0.05) ( Figure 5 ). The genes of module "yellow" could separate patients with different prognosis and the error rate of cross-validation was 0.041. Cox regression analysis was conducted for the 65 genes in the "yellow" module to find out genes closely associated with survival time. With the adjusted p-value < 0.1 as the cut-off, a total of 17 genes were revealed ( Supplementary Table 3 ), such as Dab homolog 2 (DAB2), aldehyde dehydrogenase 2 family (ALDH2), CD58 molecule (CD58), Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 (CITED2) and BCL2/adenovirus E1B 19kDa interacting protein 3-like (BNIP3L).
Discussion
In present study, we acquired a total of 3210 GC-related genes through differential analysis of 3 gene expression data sets. Functional enrichment analysis was applied on these genes. Cell proliferation and apoptosis were significantly enriched, which were closely related to cancer development. Pathway enrichment analysis showed that viral carcinogenesis, EBV viral infection, and PI3K-AKT signaling pathway were significantly over-represented in the DEGs. Epstein-Barr virus (EBV) has been linked to GC [27, 28] . The EBV is detected in the tissue of about 10% of gastric carcinoma cases throughout the world. Takada et al. report that EBV contributes to the maintenance of the malignant phenotype of EBV positive GC [28] . Phosphatidylinositol-3-kinase (PI3K) is a lipid kinase and produces phosphatidylinositol-3,4,5-trisphosphate (PI(3, 4, 5)P3), a second messenger essential for the translocation of Akt to the plasma membrane where it is phosphorylated and activated by phosphoinositide-dependent kinase (PDK) 1 and PDK2. Activation of Akt plays a pivotal role in fundamental cellular functions such as cell proliferation and survival by phosphorylating a variety of substrates. PI3K-AKT signaling pathway has been closely associated with various aspects of cancers [29, 30] . Osaki et al. report that inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human GC cell line, MKN-45 [31] . These significantly enriched biological processes and pathways confirmed the reliability of the DEGs.
To screen out key genes associated with prognosis in GC patients, another gene expression data set was obtained, based upon which a weighted gene co-expression network was constructed with WGCNA method. A total of 7 modules were identified. Finally, a total of 17 genes were closely related to survival time and thus were considered as signature genes. Some of them have been implicated in GC according to previous studies, such as DAB2 [32] , ALDH2 [33] , CD58 [34] , CITED2 [35] and BNIP3L [36] .ALDH2 belongs to the aldehyde dehydrogenase family of proteins. Aldehyde dehydrogenase is the second enzyme of the major oxidative pathway of alcohol metabolism. Shin et al. find that ALDH2 polymorphisms modify the susceptibility to the development of GC associated with alcohol intake [37] . Wang et al. carry out a meta-analysis and suggest that ALDH2 and ADH1 genetic polymorphisms may play crucial roles in the pathogenesis of GC [33] . Mayer et al. find that expression of CD56 by more than 50% of the tumor cells correlates with tumor recurrence and decreased survival time and it may be involved in the development of distant metastases of GC [34] .CITED2 is a gene that mediates sensitivity to chemotherapeutics. Regel et al. indicate that levels of CITED2 in gastric tumors correlate with patients' response to epirubicin [35] , suggesting it might be a therapeutic target to modulate chemotherapy and thus benefit prognosis.
With regard to the other genes (or the protein products), SLC43A2 (Solute carrier group of membrane transport protein, member 2), a Na+-independent transporter that has significant role in the transport of macromolecule amino acid across membranes, is verified to be elevated in most metastatic GCs [38] . This cancer-related protein is reported associated with the pancreatic cancer survival [39] . These provide potent evidence that SLC43A2 might also be implicated in GC survival time, as suggested in our results. In breast cancer, the homologous FAU gene (Finkel-Biskis-Reillymurine sarcoma virus) is found in the region of 11q13~q14, which other cell cycle-related genes are also located, and acts as a tumor suppressor in vitro [40] . However, at present, no data indicate the association between this gene and GC, suggesting that FAU might be a novel indicator for the prognosis of GC. Overexpression of the collagen COL5A1 is discovered in malignant lesion of stomach, suggesting the important role of COL5A1 in the GC progression [41] . These illustrations collectively suggest that the three genes might be novel biomarkers for the GC prognosis.
Overall, 17 genes significantly linked with survival time of GC patients were disclosed in present study. First, they could be used for prognosis. Second, some of them might be potential targets and thus could be exploited for GC therapy. Besides, the 3210 GC-related genes could also provide clues for future researches on GC. 
